Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP364255.RA_6fjpJ14Hyzaog4Fq608NDtlEUdiGClYJdkjrPFbxYg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP364255.RA_6fjpJ14Hyzaog4Fq608NDtlEUdiGClYJdkjrPFbxYg130_assertion type Assertion NP364255.RA_6fjpJ14Hyzaog4Fq608NDtlEUdiGClYJdkjrPFbxYg130_head.
- NP364255.RA_6fjpJ14Hyzaog4Fq608NDtlEUdiGClYJdkjrPFbxYg130_assertion description "[Studies of glioma xenografts suggest that they may be amenable to gene therapy with cytotoxic genes, such as the proapoptotic Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand (Apo2L/TRAIL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP364255.RA_6fjpJ14Hyzaog4Fq608NDtlEUdiGClYJdkjrPFbxYg130_provenance.
- NP364255.RA_6fjpJ14Hyzaog4Fq608NDtlEUdiGClYJdkjrPFbxYg130_assertion evidence source_evidence_literature NP364255.RA_6fjpJ14Hyzaog4Fq608NDtlEUdiGClYJdkjrPFbxYg130_provenance.
- NP364255.RA_6fjpJ14Hyzaog4Fq608NDtlEUdiGClYJdkjrPFbxYg130_assertion SIO_000772 17178885 NP364255.RA_6fjpJ14Hyzaog4Fq608NDtlEUdiGClYJdkjrPFbxYg130_provenance.
- NP364255.RA_6fjpJ14Hyzaog4Fq608NDtlEUdiGClYJdkjrPFbxYg130_assertion wasDerivedFrom befree-20140225 NP364255.RA_6fjpJ14Hyzaog4Fq608NDtlEUdiGClYJdkjrPFbxYg130_provenance.
- NP364255.RA_6fjpJ14Hyzaog4Fq608NDtlEUdiGClYJdkjrPFbxYg130_assertion wasGeneratedBy ECO_0000203 NP364255.RA_6fjpJ14Hyzaog4Fq608NDtlEUdiGClYJdkjrPFbxYg130_provenance.